AzTrials
AzTrials

Periapical LesionsNCT05538104

The Accuracy of Computer Aided Detection of Periapical Radiolucencies on Cone -Beam Computed Tomography Images Using Artificial Intelligence

An observational study of Periapical Lesions, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

A diagnostic accuracy study to assess the accuracy of a newly developed deep learning model in the automatic detection of periapical radiolucent lesions of upper and lower jaws by comparing it with experienced radiologists' opinion, which represents the ground truth. Read more about this study

Who is it for?
Any age
Conditions the study is for
Periapical Lesions
How many people
50 participants
Where
No sites listed yet
Study dates
Sep 2022to Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Child, Adult, Older adult

Study population: The CBCT data of this study will be obtained from the CBCT data base available at the department of Oral and Maxillofacial Radiology, Faculty of Dentistry, Cairo University, Cairo, Egypt and from available online data set with different CBCT machines. CBCT scans of Egyptian patients who have already been subjected to CBCT examination as part of their dental diagnosis and/or treatment planning will be included according to the proposed eligibility criteria. .

Who may be able to join

  • • CBCT scans of maxilla and mandible with good quality free pf periapical radiolucent lesions .
  • CBCT scans of maxilla and mandible with good quality showing periapical radiolucent lesions

Who cannot join

  • • CBCT images of sub-optimal quality or artifacts / high scatter interfering with proper assessment.

About this study

Official title: The Accuracy of Computer Aided Detection of Periapical Radiolucencies on Cone -Beam Computed Tomography Images Using Artificial Intelligence: Diagnostic Accuracy Study.

A diagnostic accuracy study to assess the accuracy of a newly developed deep learning model in the automatic detection of periapical radiolucent lesions of upper and lower jaws by comparing it with experienced radiologists' opinion, which represents the ground truth.

Hypothesis: The null hypothesis is that the results of the deep learning model are as accurate as the radiologists' opinion.

Read the detailed description
  • Study Design: A diagnostic accuracy study
  • Setting and Location: Retrospective data collection is planned before the index test and reference standard are to be performed. The CBCT data of this study will be obtained from the CBCT data base available at the department of Oral and Maxillofacial Radiology, Faculty of Dentistry, Cairo University, Cairo, Egypt and from available online data set with different CBCT machines.

CBCT scans of Egyptian patients who have already been subjected to CBCT examination as part of their dental diagnosis and/or treatment planning will be included according to the proposed eligibility criteria.

  1. Participants:

Based on sample size calculation, a sample of 50 periapical radiolucent lesions of upper and lower different locations in jaw found in CBCT scans. The selection of the scans to be included will be based on the following eligibility criteria.

Inclusion criteria:

  • CBCT scans of maxilla and mandible with good quality free pf periapical radiolucent lesions .
  • CBCT scans of maxilla and mandible with good quality showing periapical radiolucent lesions.

Exclusion criteria:

  • CBCT images of sub-optimal quality or artifacts / high scatter interfering with proper assessment.
  1. Variables:
  • Details about variable CBCT data with periapical lesions were anonymized in DICOM format, and Then, the files will be forwarded to mathematical engineering department faculty of engineering Cairo university for implementing the deep learning model which will include two phases.
  1. Data Sources / Measurements:
  • CBCT scans of anonymized retrospective data will be used for research, without the active involvement of patients. Different CBCT machines scans will be used and preliminarily imported into CBCT viewer software program Blue Sky Bio to detect the periapical radiolucent lesions.

Localization datasets.

  1. Incisors-canines (anterior teeth) Maxillary Mandibular
  2. premolars -molars (posterior teeth) Maxillary Mandibular

CBCT data with periapical lesions were anonymized in DICOM format, and Then, the files will be forwarded to mathematical engineering department faculty of engineering Cairo university for implementing the deep learning model which will include two phases.

Training and validation phase Testing phase Test set separation. Following the completion of the first stage of annotation, a test was separated from the annotated data pool and excluded from all following development activities.

Model development dataset. A set for model development purposes formed from the remaining annotated data pool (i.e. not included in the test set) was split into training and validation subsets as it was ft for the task.

As the performance of deep learning-based methods heavily relies on a large number of labeled datasets. Existing CNN-based methods (12, 16) first pre-train their model on available online dataset. Therefore, we will use an available online dataset provided by Abdolali et al as data used in their study (18) for research work and then fine tune the network on our collected sample.

The exact number of the scans to be used for training can change to avoid underfitting or overfitting in the model, So it will be exactly assigned by the engineering mathematic engineering department faculty of engineering Cairo university.

  1. Addressing potential sources of bias:

No source of bias. The index text will be carried out by a computer program which will be blinded from the ground truth set by 2 well experienced radiologists prior to conduction of this index test. he assessor of the reference standard will not be subjected to the results of the index test as both the gold standard and the index test results will be tabulated and sent to the statistician finally for comparison by a different person rather than the assessors.

  1. Study Size:

A power analysis was designed to have adequate power to apply a two-sided statistical test of the null hypothesis that results of deep learning model are as accurate as the radiologist opinion. By adopting a (95%) confidence interval and by using a specificity value of (88.0%) of the DL group based on the results of a previous study (20) (21) and 100 % for the ground truth: sample size calculated based on specificity was (50) samples. Sample size calculation was performed using Connor equation.

  1. Sampling strategy: random sampling. H) Quantitative variables
  2. Statistical methods: sensitivity, specificity, positive predictive value, and negative predictive value will be calculated and graded according to the ranking for diagnostic tests by Leonardi Dutra et al (19) with scores .80% considered excellent outcomes, between 70% and 80% good, between 60% and 69% fair, and ,60% as poor. Teeth without periapical radiolucency served as controls.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. • Accuracy of automatic detection of periapical radiolucent lesions on CBCT images.

    • The computer generated deep learning model.
    • Well experienced radiologists' vision and interpretation of CBCT images in optimum viewing conditions. Using CBCT viewer software program Blue Sky Bio. unit : yes or no

    Measured: 1year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2022
  2. Study startSep 2022 (estimated)
  3. Primary completionAug 2023 (estimated)
  4. Study completionDec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05538104
Sponsor's protocol ID
ORAD 7,1,1
Status last verified
Sep 2022
First submitted
9 Sep 2022
Last updated
13 Sep 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Periapical Lesions, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

• Accuracy of automatic detection of periapical radiolucent lesions on CBCT images. (time frame: 1year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in